Jeff is a corporate attorney who advises life science companies executing M&A, divestiture, financing, joint venture, licensing and commercial transactions. He serves as outside general counsel to life science companies and has significant experience advising digital health companies as they navigate the myriad legal issues related to the growing use of artificial intelligence, smart algorithms and “big data” in medical technology.
Before joining Fredrikson & Byron, Jeff founded and led a consulting firm that provided general counsel services and strategic advice to life science companies, including serving as the General Counsel of Vios Medical, Inc., an emerging growth healthcare information technology company with an IoT-based patient management platform delivered as a service, prior to its sale to Murata Manufacturing Company in the fall of 2017. Previously, Jeff was the Vice President of Business Law and Deputy General Counsel of SUPERVALU, INC. where he led the legal teams advising the company and developing strategies related to the company’s M&A, securities, financing and real estate activities. Jeff also developed substantial medical technology expertise during his time at Medtronic as an M&A lawyer, corporate development leader and divisional counsel and has a strong background in healthcare law. Prior to joining Medtronic, Jeff was a corporate and restructuring attorney at Skadden, Arps, Slate Meagher & Flom.
Jeff serves on the Boards of Directors and Executive Committees of Pillsbury United Communities and the Minneapolis Heart Institute Foundation and the Board of Directors of the South Dakota Biotech Association.
